IMMU-16. ANTI-VEGF TREATMENT EFFECT AGAINST GLIOMA IS IMMUNE DEPENDENT AND MEDIATED BY ENHANCED T CELL ACTIVITYCécile L. Maire, Katrin Lamszus, Sarina Heinemann et al.|Neuro-Oncology|2024Cited by 1
IMMU-01. IMMUNE PHENOTYPING OF BRAIN METASTASIS PATIENTS IDENTIFIES A DISTINCT DEPLETION AND EXHAUSTION PHENOTYPE OF THE CD4 T CELLS IN BLOOD AND BONE MARROWMerle Reetz, Malte Mohme, Alice Ryba et al.|Neuro-Oncology|2023Cited by 0